Press releases

Month Year

Email alerts

Nov 1, 2016

Medtronic CoreValve(TM) Evolut R(TM) System Shows Exceptional Clinical Outcomes at One Year

New Data from Evolut R U.S. IDE study presented at TCT Reveals Positive Clinical Performance for the Recapturable TAVR Device, Including the First-of-its-Kind 34 mm Valve

DUBLIN and WASHINGTON, D.C. - Nov. 1, 2016 - Medtronic plc (NYSE: MDT) unveiled new clinical data showing that patients treated with the self-expanding CoreValve(TM) Evolut(TM) R System continued...
Nov 1, 2016

Medtronic Harmony(TM) Transcatheter Pulmonary Valve Demonstrates Positive Early Clinical Outcomes at One Year

FDA Approves IDE Study Initiation Following Positive Results from First-of-its-Kind Early Feasibility Study Presented at TCT

DUBLIN and WASHINGTON, D.C. - Nov. 1, 2016 - Medtronic plc (NYSE: MDT) today announced new clinical data for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study,...
Oct 31, 2016

New Data on Medtronic Evolut(TM) R TAVR System Show Excellent 'Real-World' Outcomes in Global Patient Population

Results from FORWARD and STS/ACC TVT Registry Demonstrate High Survival and Low Rate of All Stroke for Next-Generation TAVR Device in Everyday Clinical Practice

DUBLIN and WASHINGTON, DC - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) today presented new positive data from two large registries aimed at evaluating 30-day clinical performance outcomes for the...
Oct 31, 2016

First Clinical Data of Medtronic Drug-Filled Stent Show Positive Outcomes

Featured 'First Report' RevElution Trial at TCT Highlights the Potential Benefits of First-of-its-Kind Polymer-Free Technology with Controlled and Sustained Drug Delivery for Rapid Vessel Healing

DUBLIN and WASHINGTON, D.C. - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) unveiled today the first clinical outcomes of its novel Drug-Filled Stent (DFS) from the RevElution Trial at the...
Oct 30, 2016

Independent Study Finds Biodegradable Polymer Stents Provide No Clinical Benefit Over Resolute Integrity(TM) DES

BIO-RESORT Demonstrates Excellent Clinical Outcomes for Medtronic Resolute(TM) Integrity(TM) DES, a Gold Standard for Percutaneous Coronary Intervention

DUBLIN and WASHINGTON, DC - Oct. 30, 2016 - Investigators today unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers analysis to compare the safety and...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa